Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: A randomized phase II pilot study

Journal of Neuro-Oncology

Volumn 93, Issue 3, 2009, Pages 349-354

  Lim, Daniel A ^a,b   Tarapore, Phiroz ^b   Chang, Edward ^a   Burt, Marlene ^a   Chakalian, Lenna ^a   Barbaro, Nicholas ^a   Chang, Susan ^a   Lamborn, Kathleen R ^a   McDermott, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anticonvulsant; Craniotomy; Glioma; Levitiracetam; Phenytoin; Seizure

Indexed keywords

ETIRACETAM; PHENYTOIN;

ADULT; AGED; ARTICLE; BALANCE IMPAIRMENT; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COORDINATION DISORDER; CRANIOTOMY; DEPRESSION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMOTIONAL DISORDER; FEASIBILITY STUDY; FEMALE; GINGIVA HYPERTROPHY; GLIOMA; HUMAN; INTERVIEW; MALE; MENTAL INSTABILITY; MONOTHERAPY; NAUSEA; NERVOUSNESS; PILOT STUDY; POSTOPERATIVE PERIOD; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN TINGLING; SLEEP DISORDER; SLURRED SPEECH; SOMNOLENCE; TELEPHONE; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PILOT PROJECTS; PIRACETAM; SEIZURES;

EID: 67349218398     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9781-4     Document Type: Article

References (26)

1. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy Of Neurology. Neurology 54:1886-1893
2. Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life. Ann Neurol 54:514-520. doi: 10.1002/ ana.10712
3. Holland KD (2001) Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurol Clin 19:313-345. doi: 10.1016/ S0733-8619(05)70021-9
4. Schachater SC (2001) Epilepsy. Neurol Clin 19:57-78. doi: 10.1016/ S0733-8619(05)70005-0
5. Wen PY, Marks PW (2002) Medical management of patients with brain tumors. Curr Opin Oncol 14:299-307. doi: 10.1097/00001622-200205000-00008
6. Chang EF, Keles GE, Chang SM, Lamborn KL, Barbaro NM, Berger MS (2005) Seizure characteristics and post-operative seizure control in patients with low-grade gliomas. Congress of Neurological Surgeons (abstract) 2005. Los Angeles, CA, USA
7. Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Pluchino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) 103:47-51. doi: 10.1007/BF01420191
8. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227-235. doi: 10.3171/ JNS/2008/108/2/0227
9. North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 58:672-677
10. Shaw MD, Foy PM (1991) Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: Discussion paper. J R Soc Med 84:221-223
11. Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 47:1087-1090. doi: 10.1136/jnnp.47.10.1087
12. Grossman SA, Sheidler VR, Gilbert MR (1989) Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 87:505-510
13. Werk EE Jr, Choi Y, Sholiton L, Olinger C, Haque N (1969) Interference in the effect of dexamethasone by diphenylhydantoin. N Engl J Med 281:32-34
14. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: Epidemiology, mechanisms, and management. Lancet Neurol 6:421-430. doi: 10.1016/S1474-4422(07)70103-5
15. Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707-724. doi: 10.2165/00003088-200443110-00002
16. Welty TE, Gidal BE, Ficker DM, Privitera MD (2002) Levetiracetam: A different approach to the pharmacotherapy of epilepsy. Ann Pharmacother 36:296-304. doi: 10.1345/aph.1A032
17. Contin M, Albani F, Riva R, Baruzzi A (2004) Levetiracetam therapeutic monitoring in patients with epilepsy: Effect of concomitant antiepileptic drugs. Ther Drug Monit 26:375-379. doi: 10.1097/ 00007691-200408000-00006
18. Newton HB, Dalton J, Goldlust S, Pearl D (2007) Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. J Neurooncol 84:293-296. doi: 10.1007/ s11060-007-9373-8
19. Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99-102. doi: 10.1007/s11060-005-9070-4
20. Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 78:157-160
21. Wagner GL, Wilms EB, Van Donselaar CA, Vecht ChJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585-586. doi: 10.1016/S1059-1311(03)00096-7
22. Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB (1981) Phenytoin-dexamethasone interaction: A previously unreported observation. Surg Neurol 16:23-24. doi: 10.1016/S0090-3019(81)80054-7
23. Akaho R (1996) The effects of antiepileptic drugs on cognition in normal volunteers. Psychiatry Clin Neurosci 50:61-69. doi: 10.1111/ j.1440-1819.1996.tb01665.x
24. Drane DL, Meador KJ (2002) Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 3:49-53. doi: 10.1016/ S1525-5069(02)00502-9
25. Mamon HJ, Wen PY, Burns AC, Loeffler JS (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 40:341-344. doi: 10.1111/j.1528-1157.1999.tb00715.x
26. Delattre JY, Safai B, Posner JB (1988) Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 38:194-198